Citations 182

TDP‐43 AMPLIFIES MEMORY LOSS AND HIPPOCAMPAL ATROPHY IN ALZHEIMER'S DISEASE

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_16 | Pages: No page available

10.1016/j.jalz.2014.07.149

ExpandedC9ORF72Hexanucleotide Repeat in Depressive Pseudodementia

JAMA Neurology | April 21, 2014 | Volume: 71 | Issue: 6 | Pages: 775

10.1001/jamaneurol.2013.6368 | PMID 24756204

Epigenetic Modifications of the C9Orf72 Gene: A Potential Biomarker of Disease?

Future Neurology | March 3, 2014 | Volume: 9 | Issue: 2 | Pages: 123-126

10.2217/fnl.14.5

Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion

Science Translational Medicine | October 23, 2013 | Volume: 5 | Issue: 208 | Pages: No page available

10.1126/scitranslmed.3007529 | PMID 24154603

Antisense oligonucleotides can correct disease-specific phenotypes in cultured motor neurons differentiated from iPSCs derived from ALS patients with a C9ORF72 repeat expansion.
P4–034: Viewing neurodegeneration beyond the tangle: The role of RNA binding proteins in Alzheimer's disease

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_18 | Pages: No page available

10.1016/j.jalz.2013.05.1422

DT‐03–02: Viewing neurodegeneration beyond the tangle: The role of RNA binding proteins in Alzheimer's disease

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_21 | Pages: No page available

10.1016/j.jalz.2013.08.014

C9ORF72 repeat expansions in cases with previously identified pathogenic mutations

Neurology | September 12, 2013 | Volume: 81 | Issue: 15 | Pages: 1332-1341

10.1212/wnl.0b013e3182a8250c | PMID 24027057

Does Obesity-Induced τ Phosphorylation Tip the Scale Toward Dementia?

Diabetes | April 23, 2013 | Volume: 62 | Issue: 5 | Pages: 1365-1366

10.2337/db12-1784 | PMID 23613550

Misregulation of human sortilin splicing leads to the generation of a nonfunctional progranulin receptor

Proceedings of the National Academy of Sciences | December 11, 2012 | Volume: 109 | Issue: 52 | Pages: 21510-21515

10.1073/pnas.1211577110 | PMID 23236149

Sortilin 1 regulates the levels of brain progranulin (PGRN), a neurotrophic growth factor that, when deficient, is linked to cases of frontotemporal lobar degeneration with TAR DNA-binding protein-43 (TDP-43)–positive inclusions (FTLD-TDP). We identified a specific splicing enhancer element that regulates the inclusion of a sortilin exon cassette (termed Ex17b) not normally present in the mature sortilin mRNA. This enhancer element is consistently present in sortilin RNA of mice and other species but absent in primates, which carry a premature stop codon within the Ex17b sequence. In the absence of TDP-43, which acts as a regulatory inhibitor, Ex17b is included in the sortilin mRNA. In humans, in contrast to mice, the inclusion of Ex17b in sortilin mRNA generates a truncated, nonfunctional, extracellularly released protein that binds to but does not internalize PGRN, essentially acting as a decoy receptor. Based on these results, we propose a potential mechanism linking misregulation of sortilin splicing with altered PGRN metabolism.
S5‐02‐02: Lessons learned from emerging mouse models of TDP‐43 proteinopathy

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_20 | Pages: No page available

10.1016/j.jalz.2012.05.1949